fibrinolysis

(redirected from secondary fibrinolysis)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to secondary fibrinolysis: fibrinolytic activity

fi·bri·nol·y·sis

 (fī′brə-nŏl′ĭ-sĭs)
n. pl. fi·bri·nol·y·ses (-sēz′)
The breakdown of fibrin, usually by the enzymatic action of plasmin.

fi′bri·no·lyt′ic (-nə-lĭt′ĭk) adj.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

fibrinolysis

(ˌfɪbrɪˈnɒlɪsɪs)
n
(Physiology) the breakdown of fibrin in blood clots, esp by enzymes
fibrinolytic adj
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014

fi•bri•nol•y•sis

(ˌfaɪ brəˈnɒl ə sɪs)

n., pl. -ses (-ˌsiz)
the disintegration or dissolution of fibrin, esp. by enzymatic action.
[1905–10; fibrin + -o- + -lysis]
fi•bri•no•lyt•ic (ˌfaɪ brə nlˈɪt ɪk) adj.
Random House Kernerman Webster's College Dictionary, © 2010 K Dictionaries Ltd. Copyright 2005, 1997, 1991 by Random House, Inc. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.fibrinolysis - a normal ongoing process that dissolves fibrin and results in the removal of small blood clots; "drugs causing fibrinolysis have been utilized therapeutically"
dissolution, disintegration - separation into component parts
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

fi·bri·nol·y·sis

n. fibrinólisis, disolución de fibrina por la acción de enzimas;
primary ______ primaria;
therapeutic ______ terapéutica.
English-Spanish Medical Dictionary © Farlex 2012

fibrinolysis

n fibrinolisis f, fibrinólisis f
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Secondary fibrinolysis occurs as a result of activation of coagulation and thrombin generation, which stimulates endothelium to produce increased amount of tissue plasminogen activator which in turn cause increased fibrinolysis.
DIC is characterized by aberrant activation of the coagulation cascade leading to initial hypercoagulability, then progressing to a secondary hypocoagulable state resulting from consumptive coagulopathy and secondary fibrinolysis. In patients with cancer, DIC can be proximately related to altered levels of various mediators of hemostasis (procoagulants, cytokines, and fibrinolytic mediators), in addition to tumor-related endothelial cell alterations and systemic depressions in hemostatic defenses [1].
In contrast to the non-activated sample, the secondary fibrinolysis pattern was found in the kaolin-activated sample (Figure 1).